Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis

NCT01480076 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
901
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen